C
Registered Workshop Attendees
Terry Adirim
Department of Homeland Security
Will Alameida
PanThera Biopharma
Jennifer Alton
Bavarian Nordic
Margaret Anderson
FasterCures
Lida Anestidou
The National Academies
Marietta Anthony
Critical Path Institute
Stacy Arnesen
National Library of Medicine/National Institutes of Health
Damon Arnold
Illinois Department of Health
Phyllis Arthur
Biotechnology Industry Organization, Inc.
Bruce Artim
Eli Lilly and Company
Guillermo Aviles-Mendoza
HHS/ASPR
Sheila Avruch
Government Accountability Office
Gerrit Bakker
ASTHO
Tali Bar-Shalom
Government Accountability Office
Cindy Bascetta
Government Accountability Office
Alison L. Bawden
Soligenix, Inc.
Ketty Belizaire
TB Alliance
Georges Benjamin
American Public Health Association
Kavita Berger
AAAS Center for Science, Technology and Security Policy
Kathleen Berst
CBMS-JVAP
Gregory Bice
ASDHA/FHP&R/DoD
Gary Bignami
PanThera Biopharma, LLC
Peter Blain
Health Protection Agency, UK
James Blumenstock
Association of State and Territorial Officials
Douglas Boenning
HHS
Brent Bomer
XOMA
Luciana Borio
FDA
Katie Brewer
American Nurses Association
Robert N. Brey
Soligenix, Inc.
Kathryn Brinsfield
Department of Homeland Security
Steve Brozak
StormBio Inc.
Greg Burel
Centers for Disease Control and Prevention/OPHPR
Stephen V. Cantrill
National Biodefense Science Board
Roberta Carlin
American Association on Health and Disability
Gail Cassell
Eli Lilly and Company
Stacey Chambers
HHS/NIH/NINDS
D. W. Chen
Department of Defense
Kelly Childress
Foley Hoag, LLP
Kenneth Cole
ODATSD (CBD/CD)/DoD
Susan Coller-Monarez
DHS
Chris Colwell
Becton Dickinson
Doug Compton
PhRMA
Francesca Cook
PharmAthene
Mark Cooke
PharmAthene
Susan Cooper
Tennessee Department of Health
Brian Corrigan
Astellas Pharma US, Inc.
Allan Coukell
The Pew Charitable Trusts
Brooke Courtney
Center for Biosecurity
Dack Dalrymple
Dalrymple & Associates, LLC
Christopher Davis
HHS
Anne De Groot
EpiVax
Walla Dempsey
HHS/NIH/NIAID
Gary Disbrow
HHS/BioMedical Advanced Research and Development Authority
Jacqueline Dombroski
AVI BioPharma, Inc.
Michael Doney
Centers for Disease Control and Prevention
Matthew Duchars
Lydia Duckworth
MITRE/HHS
Melissa Dupree
Fabiani & Company
Diana Elkis
PRTM
Peter Emanuel
OSTP, White House
David Evans
U.S. Army Medical Research & Materiel Command
Daniel Fagbuyi
Children’s National Medical Center
Ann Farese
University of Maryland
Anthony Fauci
NIAID
Stuart Feldman
Sanofi Pasteur
Philip Ferro
HHS/ASPR
Patrick Flavin
Advanced Life Sciences, Inc.
Erin Fowler
HHS
Thomas Frieden
Centers for Disease Control and Prevention
Chuck Fromer
Chemical Biological Defense Directorate
Thomas Fuerst
HHS/ASPR
Nick Fullenkamp
Emergent BioSolutions
Claudia Gaffey
FDA
Alexander Garza
Department of Homeland Security
Bruce Gellin
HHS
Jeanne Geyer
FDA
Brent Gibson
Atlas Research, LLC
David Gilbert
Providence Health & Services
Brett Giroir
Texas A&M
Lewis Goldfrank
New York University School of Medicine
Mark Goldberger
Abbott Labs
Michael Goldblatt
Functional Genetics
Phillip Gomez
PRTM
Jesse Goodman
FDA
Frank Gottron
Congressional Research Service, U.S. Library of Congress
John Grabenstein
Merck & Co., Inc.
Dwayne Grant
HHS/OIG
Gigi Gronvall
Center for Biosecurity of UPMC
Robert Guidos
Infectious Diseases Society of America
Elin Gursky
ANSER
James Guyton
PRTM Management Consultants
Jami Haberl
Safeguard Iowa Partnership
Jeff Hackman
Intercell
Nate Hafer
NIH/OD
Marlene Haffner
Haffner Associates, LLC
Veronica Hall
Emergent BioSolutions
Michael Handrigan
HHS/ASPR
Julie Hantman
HHS/ASPR/BARDA
Maureen Hardwick
Alliance for Biosecurity
Chandresh Harjivan
PRTM
Richard Hatchett
White House, Executive Office of the President
Herbert Hecht
Emergent BioSolutions
William Helming
PRTM Management Consultants
D. A. Henderson
Center for Biosecurity of UPMC
David G. Henry
National Governors Association
Jack Herrmann
National Association of County and City Health Officials
Penny Hitchcock
Tauri Group
Sally Hojvat
OIVD/CDRH/FDA
Mary Homer
HHS/ASPR
Omar Hottenstein
Office of the Assistant Secretary of Defense for Health Affairs
Robert House
DynPort Vaccine Company, LLC
Jay Hunter
University of Maryland School of Medicine
Jean Hu-Primmer
FDA/Office of Counterterrorism and Emerging Threats
Patrick Iversen
AVI Biopharma
Rick Jaffe
ANSER, Inc., in support of ODATSD (CBD/CD)
James James
American Medical Association
Paul Jarris
Association of State and Territorial Health Officials
Daniel Jernigan
Centers for Disease Control and Prevention
David Jett
NIH/NINDS
Kelly Johnson
Agency for Healthcare Research and Quality
Vicki Johnson
National Commission on Children and Disasters
Jerry Johnston
National Association of Emergency Medical Technicians
Til Jolly
U.S. Department of Homeland Security, Office of Health Affairs
Robert Kadlec
PRTM Management Consultants
Brian Kamoie
White House, Executive Office of the President
Lisa Kaplowitz
Alexandria Health Department
James Kenimer
Biologics Consulting Group
John Kenten
Meso Scale Diagnostics
Thomas Keuer
ARCA biopharma, Inc.
Rima Khabbaz
Centers for Disease Control and Prevention
Lynne Kidder
Business Executives for National Security
Hye-Joo Kim
Centers for Disease Control and Prevention/Regulatory Affairs
Lisa Koonin
Centers for Disease Control and Prevention
George Korch
HHS
Akhila Kosaraju
SIGA
Nik Koterski
U.S. Army Medical Research & Material Command
Gerald Kovacs
HHS/BioMedical Advanced Research and Development Authority
Jon Krohmer
Department of Homeland Security
Michael Kurilla
National Institute of Allergy and Infectious Diseases
Laura Kwinn
HHS
Anne Laffoon
Government Accountability Office
Randy Larsen
Commission on the Prevention of Weapons of Mass Destruction Proliferation and Terrorism
Michael Latham
Centers for Disease Control and Prevention
Catherine Laughlin
DMID, NIAID
James Lawler
White House, Executive Office of the President
Matthew Lawlor
HHS/ASPR/BARDA
Theresa Lawrence
HHS
Eva Lee
Center for Operations Research in Medicine and HealthCare, School of Industrial and Systems Engineering,
Georgia Tech University
Janet Leigh
LSU Health Sciences Center
Brad Leissa
FDA/CDER/OCTEC
Rachel Levinson
Office of the Vice President for Research and Economic Affairs,
Arizona State University
Deborah Levy
Division of Healthcare Quality Promotion, CDC
Thomas Lilburn
Bayer Healthcare, LLC
Carol Linden
HHS/BARDA
Alicia Livinski
National Library of Medicine, National Institutes of Health
Cynthia Love
National Library of Medicine, National Institutes of Health
Daniel Lucey
Georgetown University Medical Center
Charles Ludlam
Former Counsel, Senator Joseph Lieberman
Former Principal Lobbyist for The Biotechnology Industry Organization
Nicole Lurie
HHS/ASPR
Boris Lushniak
FDA
Jayne Lux
National Business Group on Health
Brian Lynch
BD Medical
Thomas MacVittie
University of Maryland, School of Medicine
Carmen Maher
FDA
Bert Maidment
NIH/NIAID
Michael Mair
HHS
Don Malinowski
HHS/ASPR/NBSB Staff
Monique Mansoura
HHS/ASPR/BARDA
Maria Marinissen
HHS/ASPR
Richard Martin
American Society for Radiation Oncology
Tyler Martin
Dynavax Technologies
James Matthews
Sanofi Pasteur
Maritza McIntyre
Bavarian Nordic
Teri Melese
UCSF School of Medicine
Raina Merchant
HHS/ASPR
Toby Merlin
Centers for Disease Control and Prevention
Jeremy Middleton
Elusys Therapeutics
Aubrey Miller
FDA
Georgianne Mitchell
City of Baltimore OEM
Thomas Monath
Kleiner Perkins Caufield & Byers
Melinda Moree
BIO Ventures for Global Health
Chanton Morel
London School of Economics
Carolina Morgan
Government Accountability Office
Erin Mullen
Rx Response
Rick Murray
American College of Emergency Physicians
Jomana Musmar
HHS/ASPR
Padma Natarajan
Infectious Diseases Society of America
Thomas Neal
MITRE
David Noll
Bavarian Nordic
Jeanne Novak
CBR International Corp.
Nancy Nurthen
Chemical Biological Defense Directorate
Michael Ochs
Infectious Diseases Society of America
Anthony Oliver
NHTSA, Office of Emergency Medical Services
Paul Owens
Lilly Research Laboratories
Christopher Ozeroff
ARCA biopharma, Inc.
George Painter
Chimerix, Inc.
Jennifer Pakiam
National Institutes of Health
Peter Palese
Mount Sinai School of Medicine, New York
Gerald Parker
HHS
John Parker
HHS
Tracy Parker
Department of Homeland Security
Peter Patriarca
Biologics Consulting Group
Andrew Pavia
University of Utah School of Medicine
Raquel Peat
FDA/CDRH/OIVD/DMD
Mary Pendergast
ARCA biopharma, Inc.
Dana Perkins
HHS/ASPR
David Perryman
Zirus, Inc.
Del Persinger
PhRMA Foundation
Cheryl Peterson
American Nurses Association
Sally Phillips
Agency for Healthcare Research and Quality
William Pinard
American Association for the Advancement of Science
Douglas Pon
Pfizer, Inc.
Elizabeth Posillico
Elusys Therapeutics
Beena Puri
FDA/CDRH/OIVD/DMD
Resha Putzrath
Navy and Marine Corps Public Health Center
Beth Rada
XOMA
Narayani Ramakrishnan
National Institute of Allergy and Infectious Diseases
Jacqueline Rams
Southern Research Institute
Stephen Redd
Centers for Disease Control and Prevention
Christopher Revere
National Commission on Children and Disasters
John Rex
AstraZeneca
Andrew Rickles
HHS/ASPR
David Ridley
Duke University
Corinne M. Ringholz
Chemical Biological Defense Directorate
Rosemary Roberts
Center for Drug Evaluation and Research, FDA
MacKenzie Robertson
HHS/ASPR
Robin Robinson
HHS
Michelle Rodrigues
SRI International
Paige Rogers
HHS/ASPR/BARDA
Eric Rose
SIGA Technologies, Inc
Philip Russell
Sabin Vaccine Institute
Jerald Sadoff
AERAS Global TB Vaccine Foundation
Elizabeth Sadove
FDA
Ronald Saldarini
Biological Initiatives
Emad Samad
StormBio
Tiffany Sampson
Department of Homeland Security
Leigh Sawyer
HHS
Patrick Scannon
XOMA
Julie Schafer
Biomedical Advanced Research and Development Authority
David Schmickel
FoxKiser
Roslyne Schulman
American Hospital Association
Talisha Searcy
HHS/OIG
Frederic Selck
Center for Biosecurity
Jonathan Shapiro
Department of Health and Human Services
Jerry Sheehan
National Library of Medicine National Institutes of Health
Marilee Shelton-Davenport
National Research Council/National Academy of Sciences
Angela Shen
National Vaccine Program Office, HHS
Thomas Shipley
Department of Homeland Security
Roxanne Shively
HHS/ASPR/BARDA
David Siegel
NIH, NICHD
Michael Skidmore
Department of Defense
Laura Smart
Chimerix
Brad Smith
Center for Biosecurity, UPMC
Frank Sokolik
The Joint Commission
Daniel Sosin
Centers for Disease Control and Prevention
Raul Sotomayor
HHS/ASPR
Sharon Stanley
American Red Cross, National Headquarters
Craig Steinman
Abbott
Tim Stephens
National Sheriffs Association
Carolyn Stevens
HHS
Tom Stewart
AVI BioPharma
Deborah D. Stine
OSTP
Brook Stone
HHS/ASPR/NBSB
Raymond Strikas
National Vaccine Program Office, HHS
Victoria Sutton
Texas Tech University School of Law
Ernie Takafuji
National Institute of Allergy and Infectious Diseases
Carmen Tamayo
Foresight Links/FIP
Janet Tobias
Ikana Media
Eric S. Toner
Center for Biosecurity, University of Pittsburgh Medical Center
John Trizzino
Novavax, Inc.
Jessica Tucker
HHS
Craig Vanderwagen
HHS/ASPR (retired)
Rajeev Venkayya
Bill & Melinda Gates Foundation
Keith Vesely
Office of the Assistant Secretary of Defense for Health Affairs
Bruce Walker
Northrop Grumman Corporation
Cole Werble
The RPM Report
Gamunu Wijetunge
Department of Transportation
Ladd Wiley
Akin Gump Strauss Hauer and Feld
Andrew Willman
National Association of County and City Health Officials
Theresa Wizemann
Wizemann Scientific Communications, LLC
April Wood
American Red Cross
Gillian Woollett
Engel & Novitt, LLP
Raymond Woosley
Critical Path Institute
Casey Wright
HHS/ASPR
David Wright
PharmAthene
Justin Wright
BD Medical
David Wurtman
NexBio, Inc.
Debra Yeskey
HHS/ASPR/BARDA
Kevin Yeskey
HHS
David Yeung
NIH/NINDS
Lauren Yeung
FDA
Wesley Yin
Boston University
Yon Yu
Centers for Disease Control and Prevention
Stephanie Zaza
Centers for Disease Control and Prevention